First presented at SLAS 2021, Solentim, launches two novel products. ICON™ is the world’s first benchtop system for characterizing high productivity clones and introducing STUDIUS™ software the new standard for cell line development. In this launch presentation learn about how these two new products build together with existing Solentim platforms to build a new data driven workflow for the development of modern cell based therapies.
Global Marketing Manager, Solentim
Duncan Borthwick has a PhD from the University of Edinburgh and University of North Carolina, Chapel Hill. Since hanging up his lab coat 20+ years ago, Duncan has worked in the development of novel instrumentation and products. He heads the Product Management group at Solentim, working closely with the R&D, biology and commercial teams to define the next set of products to support the cell therapy community.
Mark Stockdale is a keen technology consultant. He started his career at Pfizer, and has also worked as a Group Leader at Horizon Discovery Ltd, a scientist within Lonza Biologics, and at Cyclacel Ltd. With over 15 years of professional experience in cell line development and drug discovery, his passion is to bring new technologies to bear on unmet needs and provide great insight into the future technology requirements in stable cell line development.
Watch the Webinar